News

AbbVie, North Chicago

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to corporate offices and manufacturing sites for AbbVie.
AbbVie (ABBV) Invests US$195 Million To Expand U.S. Pharmaceutical Production
AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API production, reflecting its long-term commitment to U.S. manufacturing. Over the last quarter,
AbbVie plans $195M expansion of North Chicago plant in U.S. production push
AbbVie is investing $195 million in its North Chicago manufacturing plant to expand domestic drug production. It's part of the company's previously announced $10 billion U.S. capital plan, which the company hopes can lessen the impact of federal tariffs on pharmaceuticals.
AbbVie to invest $195 million in US drug ingredient manufacturing
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, jobs, and production of next-generation medicines.
Wintrust Business Minute: AbbVie to spend $200 million to expand North Chicago manufacturing plant
Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will spend nearly $200 million to expand its manufacturing plant in North
AbbVie investing $195 million to expand manufacturing footprint in Illinois
AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North Chicago manufacturing facility. The investment will strengthen AbbVie’s
AbbVie to Invest $195M in Chicago Manufacturing Plant
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the U.S.
Pritzker Announces $195 Million Investment From AbbVie To Expand Footprint In Illinois
NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today announced the company’s
AbbVie expands North Chicago API production with $195m investment
AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This development is part of a larger commitment by the company to invest more than $10bn in US capital for innovation and critical manufacturing capacity enhancement.
AbbVie announces $195M investment to expand API manufacturing in U.S.
AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient
Illinois secures AbbVie’s $195 million investment for North Chicago facility
AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.
PharmExec1d

AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...
Chicago Tribune2y

Thousands of AbbVie volunteers sprucing up North Chicago schools; ‘We ...

The volunteers from North Chicago-based AbbVie’s corporate offices and manufacturing facilities in the area, and more than 14,000 worldwide, are participating in the company’s eighth-annual ...